(Q33449519)

26 July 2017

1 reference

title

Management of hemolytic-uremic syndrome (English)

1 reference

hemolytic-uremic syndrome

26 July 2017

main subject

1 reference

Siegler RL

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 1988

1 reference

The Journal of Pediatrics

26 July 2017

published in

1 reference

26 July 2017

volume

112

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

1014-1020

1 reference

Current concepts. Postpartum renal failure

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Hypertension and segmental renal hypoplasia causing a syndrome of haemolysis and uraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Lupus glomerulonephritis with thrombotic microangiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Recurrent hemolytic uremic syndrome and metastatic malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Hemolytic Uremic Syndrome in Families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Haemolytic-uraemic syndrome in typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Hemolytic-uremic syndrome associated with Streptococcus pneumoniae. Report of a case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Experimental studies on the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Effect of sublingual or oral nifedipine in the treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Hemorrhagic cerebral infarction in the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Coagulation findings in the hemolytic-uremic syndrome of infancy: Similarity to hyperacute renal allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Heparin therapy in the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Preliminary report: Treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Treatment of the hemolytic-uremic syndrome with streptokinase and heparin (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Endarterial urokinase in childhood hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Prostanoids in hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Deficiency of plasma PGI2-like regenerating activity in neonatal plasma. Reversal by vitamin E in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Vitamin E. An inhibitor of the platelet release reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Modulation of Platelet thromboxane A2 and arterial prostacyclin by dietary vitamin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

Vitamin E treatment of haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980239-7

10.1016/S0022-3476(88)80239-7

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference